Clinical and hemodynamic profile of patients with advanced heart failure considered for heart transplantation

V Ortiz1, L Martínez-Dolz, E Sánchez-Lacuesta

  • 1Unidad de Insuficiencia Cardiaca y Trasplante, Servicio de Cardiología, Hospital Universitario La Fe, Valencia, Spain. vortiz@comv.es

Transplantation Proceedings
|September 25, 2007
PubMed

Insights

Patients undergoing heart transplantation (HT) show similar clinical and hemodynamic profiles regardless of prior heart disease. Strict transplant criteria may homogenize patient characteristics before advanced heart failure treatment.

Area of Science:

  • Cardiology
  • Transplantation Medicine

Background:

  • Advanced heart failure necessitates evaluation for heart transplantation (HT).
  • Prior cardiac disease may influence pre-transplant clinical and hemodynamic status.
  • Understanding these differences is crucial for optimizing HT candidacy.

Purpose of the Study:

  • To evaluate the clinical and hemodynamic status of advanced heart failure patients considered for HT.
  • To investigate the impact of underlying cardiac disease (ischemic heart disease, dilated cardiomyopathy, valvular disease) on pre-transplant parameters.

Main Methods:

  • Analysis of pre-transplant clinical, echocardiographic, and hemodynamic data from 422 HT patients.
  • Exclusion of pediatric, heart-lung, and re-transplant cases.
  • Comparison of patient groups based on the etiology of heart failure: ischemic heart disease (IHD), dilated cardiomyopathy (DMC), or valvular disease.

Main Results:

  • Baseline characteristics varied: IHD patients more frequently male with hypertension and diabetes; DMC patients were younger.
  • No significant differences observed in clinical parameters (liver/kidney function, functional class, inotropic support).
  • Hemodynamic parameters (pulmonary pressures, resistance) and echocardiographic findings (ventricular size, ejection fraction) showed variations, particularly greater ventricular dimensions and reduced ejection fractions in DMC patients.

Conclusions:

  • Patients with advanced heart failure awaiting HT exhibit comparable clinical and hemodynamic profiles irrespective of the underlying cardiac disease.
  • Strict selection criteria for heart transplantation may lead to a homogeneous group of candidates.
  • These findings suggest that the severity of heart failure, rather than its etiology, dictates the pre-transplant status in this highly selected cohort.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.